Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €109.00 | €116.99 | 7.332% |
| Humana Inc. | 23 | 0 | 3 | 0 | €305.20 | €439.88 | 44.127% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.23 | €19.86 | 218.859% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €200.00 | - | - |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.90 | €8.75 | 10.759% |
| Evolus Inc | 9 | 0 | 4 | 0 | €12.10 | €20.43 | 68.864% |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €251.80 | €445.58 | 76.959% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €25.00 | - | - |
| XOMA Corp. | 6 | 0 | 3 | 0 | €22.00 | €68.78 | 212.633% |
| Koninklijke Philips Electronics ADR | 2 | 1 | 0 | 0 | €24.00 | - | - |
| Heron Therapeutics Inc. | 10 | 1 | 4 | 0 | €2.75 | €4.58 | 66.315% |
| Chemed Corp. | 5 | 0 | 1 | 0 | €535.00 | €588.14 | 9.933% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.56 | €38.19 | 95.264% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €119.50 | €130.44 | 9.153% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
| Sanofi S.A. | 5 | 0 | 1 | 0 | €93.45 | €99.50 | 6.474% |
| Select Medical Holdings | 6 | 0 | 4 | 0 | €30.60 | €36.41 | 18.975% |
| Twist Bioscience Corp | 7 | 0 | 4 | 0 | €39.52 | €41.41 | 4.780% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €86.00 | €97.90 | 13.840% |
| Dexcom Inc. | 18 | 0 | 2 | 0 | €119.84 | €136.82 | 14.171% |
| Celldex Therapeutics | 10 | 1 | 1 | 0 | €38.40 | €51.25 | 33.453% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.77 | €10.05 | 110.599% |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €72.96 | 6.506% |